Pliant Therapeutics Inc (PLRX)

Pliant Therapeutics Inc stock is traded at $0.8051, with a volume of 49,845. It is down -1.31% in the last 24 hours and down -21.83% over the past month. Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.